HK2 and cancer: Increasing evidence suggests that HK2 is upregulated in various types of tumors, correlating with enhanced aerobic glycolysis.The upregulation of HK2 expression can be attributed to fibroblast growth factor (FGF), which enhances the expression of MYC, one of the most frequently dysregulated driver genes in human cancers.